Two epigenetically distinct types of obesity identified

Medicover Genetics Editorial Team|

Scientifically checkedView our editorial guidelines
Scientifically checked

Scientists have discovered two distinct types of obesity with physiological and molecular differences that may have lifelong implications for health, disease, and drug response. The study, published in , offers a more nuanced understanding of obesity than current definitions and may provide more accurate ways to diagnose and treat obesity and related metabolic disorders. The results also reveal new details about the role of epigenetics and provide insight into the link between insulin and obesity.

About two billion people worldwide are considered overweight and there are over 600 million people with obesity. Currently, obesity is diagnosed using body mass index (BMI), an index correlated to body fat generated by comparing weight and height. However, it does not consider factors such as muscle mass, bone density, age, sex, or ethnicity, which can lead to misrepresentation of a person’s health status.

Obesity subtypes

Using a combination of laboratory studies on mouse models and data analysis from TwinsUK, a study cohort developed in the UK, the researchers discovered four metabolic subtypes that affect individual body types: two prone to leanness and two prone to obesity.

One obesity subtype is characterised by greater fat mass while the other was characterised by both greater fat mass and lean muscle mass. Unexpectedly, the team found that the second type of obesity was also associated with increased inflammation, which may increase the risk of certain cancers and other diseases. Both subtypes have been observed in several study cohorts, including children. These findings are an important step in understanding how these different types affect disease risk and treatment response.

Obesity subtypes in a mouse model

After identifying the subtypes in the human data, the team verified the results in mouse models. This approach allowed the scientists to compare genetically identical individual mice raised in the same environment and fed the same amounts of food. The study found that the inflammatory subtype appears to result from epigenetic changes that were triggered purely randomly. They also found that there did not seem to be any middle ground, meaning genetically identical sibling mice grew or stayed smaller, with no gradient between them. A similar pattern was seen in data from more than 150 pairs of human twins, each of which was genetically virtually the same.

The laboratory results were consistent with data from human twins. They again saw two distinct subtypes of obesity, one of which appeared to be epigenetically “triggered” and characterised by higher lean mass and fat, strong inflammatory signals, high insulin levels, and a strong signature epigenetics.

Unexplained phenotypic variation and epigenetics

Depending on the calculation and traits in question, only 30-50% of human trait results can be linked to genetic or environmental factors. This means that half of who we are is governed by something else. This phenomenon is called unexplained phenotypic variation (UPV) and offers both a challenge and untapped potential.

The study indicates that the roots of UPV likely lie in epigenetics, the processes that determine when and to what extent instructions in DNA are used. Epigenetic mechanisms are the reason that individuals with the same genetic blueprint, like twins, can develop different traits such as eye colour and hair colour. Epigenetics also offers tantalising targets for precision treatment. Epigenetics can act as a light switch that turns genes on or off, which can promote health or disease.

Last updated: 11.09.2026

Latest articles

All about genetics
Health and well-being
Hereditary diseases
  • VERACITY

    New-generation non-invasive prenatal screening from week 9 of pregnancy, analysing fetal cell-free DNA in maternal blood to detect selected chromosomal abnormalities with high sensitivity and specificity for early and reliable prenatal risk assessment.

  • Pharmacogenomics

    Enabling personalised treatments for safer, more effective care through genetic insights that guide optimal prescribing from the start and refine therapy when patients experience side effects or poor response.

  • ebiom+

    A comprehensive assessment of the endometrial microbiome and chronic endometritis pathogens to enhance clinical outcomes, prevent treatment delays, and support a more informed, personalised fertility care.

  • WES

    Advanced sequencing that simultaneously analyses a broad range of genes to detect the genetic basis of complex diseases, improve diagnostic accuracy, and inform recurrence risk assessment for better clinical decision-making.

Why Medicover Genetics

Leader in genetic testing with >25 years of experience in counselling and diagnostics

Comprehensive CE-IVD kit portfolio and seamless Technology Transfer solution for laboratories of any size

End-to-end clinical workflow from sample processing to sequencing analysis and reporting

CAP- and CLIA- and ISO15189 accredited, GMP- and ISO9001 and 13485 certified

Are you a patient?

Are you a physician?